Vilon Peptide X 20mg
Regular price
Rs. 9,816
- Unit price
- per
100% Authentic
Made in USA
Authorised distributor
1-5 Days delivery
Vilon Peptide X 20mg
Regular price
Rs. 9,816
- Unit price
- per
Price includes all duties and taxes
SKU: VILON-20MG
FMI's Choice
Vilon is a synthetic dipeptide bioregulator composed of L‑lysine and L‑glutamic acid (Lys‑Glu). Classified as a Khavinson peptide bioregulator, it is designed for research use only and has been studied for its role in immune system regulation and thymus function. As one of the shortest active peptide bioregulators, Vilon provides a unique model for examining cellular aging mechanisms and immune modulation in vitro.
Mechanistic Claims
- Immune System Modulation: Influences thymus‑related pathways and lymphocyte responses.
- Cellular Aging Research: Studied for effects on heterochromatin organization and cellular senescence.
- Anti‑Aging Potential: Demonstrates measurable activity in laboratory models of immune regulation.
- Tumor Research Applications: Explored for roles in immune response modulation in tumor studies.
- Minimalist Structure: As a dipeptide, offers a simplified yet potent bioregulatory model.
Research Applications
- Thymus and immune system investigations
- Lymphocyte response modulation studies
- Cellular aging and heterochromatin organization research
- Tumor biology and immune regulation models
- Exploratory anti‑aging peptide bioregulator studies
Vilon Research Insights
- Synthetic dipeptide (Lys‑Glu) developed as part of Khavinson’s peptide bioregulator program.
- Functions as a potent research compound targeting thymus‑related immune pathways.
- Evidence highlights roles in immune modulation, cellular aging, and tumor research.
- Supplied in research‑grade, lyophilized form (freeze‑dried, filler‑free) to preserve purity and stability.
- For research use only; not intended for human or veterinary therapeutic application.
Vilon Bioregulator Research
Vilon peptide represents one of the shortest bioactive compounds studied in laboratory research, consisting of just two amino acids (Lys-Glu). Scientific investigations reveal this dipeptide demonstrates measurable effects across multiple cellular pathways in controlled research environments.
Gene Expression Regulation
Laboratory studies show KE peptide binds directly to double-stranded DNA in cell nuclei, specifically targeting GCGC sequences found in 642 gene promoters[1]. This binding mechanism allows the peptide to regulate multiple genes simultaneously in research cell cultures[2].
Research demonstrates the peptide interacts with histone proteins, potentially altering chromatin structure in laboratory conditions. These modifications may influence gene accessibility and transcription factor binding in controlled studies[1].
Immune System Modulation
In vitro experiments reveal Vilon modulates cytokine production in cultured immune cells. The peptide specifically targets the CHUK gene, which encodes components for NF-κB signaling pathway regulation[1].
Laboratory research shows the compound stimulates T-cell differentiation and promotes CD4 and CD5 molecule expression in thymic cell cultures. Studies demonstrate up to 6-fold reduction in inflammatory cytokine synthesis in stimulated cell preparations[2].
Cellular Aging Research
Research indicates Vilon normalizes telomere length in stimulated lymphocyte cultures across different age groups in laboratory conditions. The peptide increases euchromatin proportion while decreasing heterochromatin in aging cell models[2].
Gene expression analysis reveals the compound regulates aging-related genes including IGF1, FOXO1, TERT, and NFκB in mesenchymal stem cell cultures. Laboratory studies show reduced apoptosis markers in aging cell preparations treated with the peptide[2].
Cardiovascular Research Applications
Studies demonstrate Vilon influences ACE2 gene expression, which encodes angiotensin-converting enzyme 2 in cardiovascular research models. The peptide also regulates AKT1 and AKT2 genes linked to cellular survival and angiogenesis pathways[1].
Metabolic and Stress Response Studies
Research shows the peptide affects heat shock protein synthesis and cellular stress response mechanisms in laboratory conditions. The compound influences genes encoding proteins involved in energy production and oxidative stress tolerance[2].
Laboratory investigations reveal Vilon regulates matrix metalloproteinase-9 expression and increases Ki-67 synthesis in cultured fibroblast preparations. These findings suggest potential applications in tissue repair research models[2].
References
-
N. Linkova et al., “The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19,” MDPI AG, Aug. 2023. doi: 10.3390/ijms241713377. Available: https://doi.org/10.3390/ijms241713377
-
V. Kh. Khavinson, N. S. Linkova, N. I. Chalisova, and O. M. Ivko, “The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity,” Pleiades Publishing Ltd, Jul. 2021. doi: 10.1134/s2079086421040046. Available: https://doi.org/10.1134/s2079086421040046
Label--Peptide Specifications
| Property | Value |
|---|---|
| Peptide Sequence | L-Lys-L-Glu |
| Molecular Formula | C₁₁H₂₁N₃O₅ |
| Molecular Weight | 275.3 g/mol |
| CAS Number | 45234-02-4 |
| PubChem CID | 7010502 |
| Synonyms | Lysylglutamic acid, N-L-Lysyl-L-glutamic acid, H-Lys-Glu-OH, Lysyl glutamate, KE |
Dosage--This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
Additional Taxes may apply for shipping to GCC
100% Authentic
Made in USA
Authorised distributor
1 - 5 days delivery
Click to read - How we deliver to India
Disclaimer
Product Information Sheet
: Not a diet substitute. Seek Medical guidance if unsure before use.
Vilon is a synthetic dipeptide bioregulator composed of L‑lysine and L‑glutamic acid (Lys‑Glu). Classified as a Khavinson peptide bioregulator, it is designed for research use only and has been studied for its role in immune system regulation and thymus function. As one of the shortest active peptide bioregulators, Vilon provides a unique model for examining cellular aging mechanisms and immune modulation in vitro.
Mechanistic Claims
- Immune System Modulation: Influences thymus‑related pathways and lymphocyte responses.
- Cellular Aging Research: Studied for effects on heterochromatin organization and cellular senescence.
- Anti‑Aging Potential: Demonstrates measurable activity in laboratory models of immune regulation.
- Tumor Research Applications: Explored for roles in immune response modulation in tumor studies.
- Minimalist Structure: As a dipeptide, offers a simplified yet potent bioregulatory model.
Research Applications
- Thymus and immune system investigations
- Lymphocyte response modulation studies
- Cellular aging and heterochromatin organization research
- Tumor biology and immune regulation models
- Exploratory anti‑aging peptide bioregulator studies
Vilon Research Insights
- Synthetic dipeptide (Lys‑Glu) developed as part of Khavinson’s peptide bioregulator program.
- Functions as a potent research compound targeting thymus‑related immune pathways.
- Evidence highlights roles in immune modulation, cellular aging, and tumor research.
- Supplied in research‑grade, lyophilized form (freeze‑dried, filler‑free) to preserve purity and stability.
- For research use only; not intended for human or veterinary therapeutic application.
Vilon Bioregulator Research
Vilon peptide represents one of the shortest bioactive compounds studied in laboratory research, consisting of just two amino acids (Lys-Glu). Scientific investigations reveal this dipeptide demonstrates measurable effects across multiple cellular pathways in controlled research environments.
Gene Expression Regulation
Laboratory studies show KE peptide binds directly to double-stranded DNA in cell nuclei, specifically targeting GCGC sequences found in 642 gene promoters[1]. This binding mechanism allows the peptide to regulate multiple genes simultaneously in research cell cultures[2].
Research demonstrates the peptide interacts with histone proteins, potentially altering chromatin structure in laboratory conditions. These modifications may influence gene accessibility and transcription factor binding in controlled studies[1].
Immune System Modulation
In vitro experiments reveal Vilon modulates cytokine production in cultured immune cells. The peptide specifically targets the CHUK gene, which encodes components for NF-κB signaling pathway regulation[1].
Laboratory research shows the compound stimulates T-cell differentiation and promotes CD4 and CD5 molecule expression in thymic cell cultures. Studies demonstrate up to 6-fold reduction in inflammatory cytokine synthesis in stimulated cell preparations[2].
Cellular Aging Research
Research indicates Vilon normalizes telomere length in stimulated lymphocyte cultures across different age groups in laboratory conditions. The peptide increases euchromatin proportion while decreasing heterochromatin in aging cell models[2].
Gene expression analysis reveals the compound regulates aging-related genes including IGF1, FOXO1, TERT, and NFκB in mesenchymal stem cell cultures. Laboratory studies show reduced apoptosis markers in aging cell preparations treated with the peptide[2].
Cardiovascular Research Applications
Studies demonstrate Vilon influences ACE2 gene expression, which encodes angiotensin-converting enzyme 2 in cardiovascular research models. The peptide also regulates AKT1 and AKT2 genes linked to cellular survival and angiogenesis pathways[1].
Metabolic and Stress Response Studies
Research shows the peptide affects heat shock protein synthesis and cellular stress response mechanisms in laboratory conditions. The compound influences genes encoding proteins involved in energy production and oxidative stress tolerance[2].
Laboratory investigations reveal Vilon regulates matrix metalloproteinase-9 expression and increases Ki-67 synthesis in cultured fibroblast preparations. These findings suggest potential applications in tissue repair research models[2].
References
-
N. Linkova et al., “The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19,” MDPI AG, Aug. 2023. doi: 10.3390/ijms241713377. Available: https://doi.org/10.3390/ijms241713377
-
V. Kh. Khavinson, N. S. Linkova, N. I. Chalisova, and O. M. Ivko, “The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity,” Pleiades Publishing Ltd, Jul. 2021. doi: 10.1134/s2079086421040046. Available: https://doi.org/10.1134/s2079086421040046
Peptide Specifications
| Property | Value |
|---|---|
| Peptide Sequence | L-Lys-L-Glu |
| Molecular Formula | C₁₁H₂₁N₃O₅ |
| Molecular Weight | 275.3 g/mol |
| CAS Number | 45234-02-4 |
| PubChem CID | 7010502 |
| Synonyms | Lysylglutamic acid, N-L-Lysyl-L-glutamic acid, H-Lys-Glu-OH, Lysyl glutamate, KE |
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
